Deubiquitinase USP47 attenuates virus-induced type I interferon signaling

Int Immunopharmacol. 2023 May:118:110040. doi: 10.1016/j.intimp.2023.110040. Epub 2023 Mar 29.

Abstract

The innate immune responses are tightly regulated to ensure effective clearance of invading pathogens and avoid excessive inflammation. Ubiquitination and deubiquitination are important post-translational modifications in antiviral immune responses. Here, we discovered deubiquitinase USP47 as a novel negative immune system regulator. Overexpression of USP47 repressed Sendai virus, poly(I:C) and poly(dA:dT)-induced ISRE and IFN-β activation, along with reduced IFNB1 transcription and enhanced viral replication. Knockdown of USP47 expression had the opposite effects. Dual-luciferase and phosphorylation assays showed that USP47 targeted downstream of MAVS and upstream of TBK1. Additional co-immunoprecipitation assays suggested that USP47 interacted with TRAF3 and TRAF6. Importantly, USP47 removed K63-linked polyubiquitin chains from TRAF3 and TRAF6. Hence, we describe a novel modulator of the antiviral innate immune response, USP47, which removes K63-linked polyubiquitins from TRAF3 and TRAF6, leading to reduced type I IFN signaling.

Keywords: Deubiquitination; Innate immunity; TRAF3; TRAF6; USP47; type I IFN.

MeSH terms

  • Antiviral Agents
  • Deubiquitinating Enzymes / metabolism
  • Immunity, Innate
  • Interferon Type I* / metabolism
  • TNF Receptor-Associated Factor 3 / genetics
  • TNF Receptor-Associated Factor 3 / metabolism
  • TNF Receptor-Associated Factor 6 / metabolism
  • Ubiquitination
  • Viruses*

Substances

  • TNF Receptor-Associated Factor 3
  • TNF Receptor-Associated Factor 6
  • Interferon Type I
  • Antiviral Agents
  • Deubiquitinating Enzymes